Bridge12 Technologies automated high-velocity microsecond freeze hyper-quenching system

The NIH intends to award a firm‑fixed‑price purchase order on a sole‑source basis to Bridge12 Technologies for an automated high‑velocity microsecond freeze hyper‑quenching system compatible with Q‑band electron paramagnetic resonance (EPR) research. The system must achieve a dead time ≤ 500 µs, a capability not met by any other identified commercial vendor. Interested parties may submit a capability statement demonstrating equivalent performance by the stated deadline. The award is expected within five days of the closing date. • Sole‑source acquisition under FAR 6.302‑1. • Required dead‑time ≤ 0.5 ms for Q‑band EPR applications. • No competing vendors meet the technical requirement. • Capability statements accepted via email to the NIH contact. • Award anticipated ~5 days after September 9, 2026 deadline.